Surrozen (SRZN)

• Market cap: $214M
• 1 day: -3.47%
• 5 days: -5.2%
• 1 month: 2.12%
• 3 months: 15.63%
• 6 months: 114.59%
• Year to date: 16.01%
• 1 year: 110.26%
• 5 years: -83.28%
• 10 years: -83.51%
• Sector: Healthcare
• Industry: Biotechnology

About: Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).

Employees: 41